Bowei Chen
Tianjin Key Laboratory On Technologies Enabling Development Of Clinical Therapeutics And Diagnostics
Tianjin, 300070, China
Tianjin, 300070, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer.
Journal: International journal of nanomedicine
Published: October 12, 2021
A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
Journal: Acta biomaterialia
Published: May 21, 2019
Corrigendum to "Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy" [Biomaterials 155C (2017) 25-40].
Journal: Biomaterials
Published: October 08, 2018
Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.
Journal: International journal of nanomedicine
Published: December 20, 2017
Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Journal: Acta biomaterialia
Published: June 19, 2017
PEGylated doxorubicin nanoparticles mediated by HN-1 peptide for targeted treatment of oral squamous cell carcinoma.
Journal: International journal of pharmaceutics
Published: December 02, 2016
Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms.
Journal: Molecules (Basel, Switzerland)
Published: October 08, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026